Resolution of a proteinuric nephropathy associated with Babesia gibsoni infection in a dog

Journal of the American Animal Hospital Association

Volumn 47, Issue 6, 2011, Pages

  Slade, Dennis J ^a,c   Lees, George E ^b   Berridge, Brian R ^b   Clubb, Fred J ^b   Kuczynski, Leslie A ^a,d   Littman, Meryl P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Veterinary Emergency and Referral Group ^*  (United States)

^d RED BANK VETERINARY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BABESIA; BABESIA GIBSONI; CANIS FAMILIARIS;

ANTIPROTOZOAL AGENT; ATOVAQUONE; AZITHROMYCIN; BACTERIAL DNA; CYCLOPHOSPHAMIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BABESIA; BABESIOSIS; CASE REPORT; DOG; DOG DISEASE; GENETICS; ISOLATION AND PURIFICATION; KIDNEY DISEASE; MALE; PATHOLOGY; POLYMERASE CHAIN REACTION; PROTEINURIA;

ANIMALS; ANTIPROTOZOAL AGENTS; ATOVAQUONE; AZITHROMYCIN; BABESIA; BABESIOSIS; CYCLOPHOSPHAMIDE; DNA, BACTERIAL; DOG DISEASES; DOGS; KIDNEY DISEASES; MALE; POLYMERASE CHAIN REACTION; PROTEINURIA;

EID: 84857669953     PISSN: 05872871     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/JAAHA-MS-5576     Document Type: Article

References (16)

1. Vaden SL. Glomerular diseases. In: Ettinger SJ, ed. Textbook of veterinary internal medicine. 6th ed. Philadelphia, PA: WB Saunders; 2005:1786-800.
2. Bovee KC, ed. Canine nephrology. USA: Harwal Publishing Company; 1984:439-58.
3. Yagi K, Yanagida H, Sugimoto K, et al. Clinicopathologic features, outcome, and therapeutic interventions in four children with isolated C3 mesangial proliferative glomerulonephritis. Pediatr Nephrol 2005;20(9):1273-8.
4. Nangaku M, Couser WG. Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol 2005;9(3):183-91.
5. Cagnoli L. Guidelines for the therapy of glomerular nephropathies. G Ital Nefrol 2003;24:S3-47.
6. Taboada J, Lobetti R. Babesiosis. In: Greene CE, ed. Infectious diseases of the dog and cat. 3rd ed. St. Louis, MO: Saunders; 2006:722-36.
7. Birkenheuer AJ, Levy MG, Breitschwerdt EB. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. J Vet Intern Med 2004;18(4): 494-8.
8. Zaragoza C, Barrera R, Centeno F, et al. Characterization of renal damage in canine leptospirosis by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) andWestern blotting of the urinary proteins. J Comp Pathol 2003;129(2-3):169-78.
9. Day MJ, Horzinek MC, Schultz RD. Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of theWorld Small Animal Veterinary Association (WSAVA). J Small Anim Pract 2007;48(9):528-41.
10. Paul MA, Carmichael LE, Childers H, et al; American Animal Hospital Association (AAHA) Canine Vaccine Task Force. 2006 AAHA canine vaccine guidelines. J Am Anim Hosp Assoc 2006; 42(2):80-9.
11. Moore GE, Guptill LF, Ward MP, et al. Adverse events diagnosed within three days of vaccine administration in dogs. J Am Vet Med Assoc 2005;227(7):1102-8.
12. Kim HJ, Park C, Jung DI, et al. A case of protein losing nephropathy in a dog infected with canine Babesia gibsoni. Korean J Vet Res 2006; 46(1):77-81.
13. Camacho AT, Guitian EJ, Pallas E, et al. Azotemia and mortality among Babesia microti-like infected dogs. J Vet Intern Med 2004;18 (2):141-6.
14. Sakuma M, Setoguchi A, Endo Y. Possible emergence of drugresistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin. J Vet Intern Med 2009;23(3):493-8.
15. Dambach DM, Smith CA, Lewis RM, et al. Morphologic, immunohistochemical, and ultrastructural characterization of a distinctive renal lesion in dogs putatively associated with Borrelia burgdorferi infection: 49 cases (1987-1992). Vet Pathol 1997;34(2): 85-96.
16. Sanders NA. Lyme nephritis. In Proceedings of 18th American College of Veterinary Internal Medicine Forum. Seattle, WA, May 25-8, 2000: 627-8. e144 JAAHA